Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm

ABSTRACT Diabetes is one of the most common human diseases and 15% of the 200 million diabetics worldwide suffer from diabetic wounds. Development of new therapeutic agents is needed for treatment of diabetic wounds. Wound healing is mediated by multiple steps, including inflammation, epithelializat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Wound repair and regeneration 2015-07, Vol.23 (4), p.575-582
Hauptverfasser: Kwon, Yang Woo, Heo, Soon Chul, Jang, Il Ho, Jeong, Geun Ok, Yoon, Jung Won, Mun, Je-Ho, Kim, Jae Ho
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 582
container_issue 4
container_start_page 575
container_title Wound repair and regeneration
container_volume 23
creator Kwon, Yang Woo
Heo, Soon Chul
Jang, Il Ho
Jeong, Geun Ok
Yoon, Jung Won
Mun, Je-Ho
Kim, Jae Ho
description ABSTRACT Diabetes is one of the most common human diseases and 15% of the 200 million diabetics worldwide suffer from diabetic wounds. Development of new therapeutic agents is needed for treatment of diabetic wounds. Wound healing is mediated by multiple steps, including inflammation, epithelialization, neoangiogenesis, and granulation. Formyl peptide receptor 2 has been known to stimulate angiogenesis, which is essential for tissue repair and cutaneous wound healing. In this study, we explored the therapeutic effects of WKYMVm (Trp‐Lys‐Tyr‐Met‐Val‐D‐Met‐NH2), a synthetic peptide agonist of formyl peptide receptor 2, on cutaneous wounds in streptozotocin‐induced diabetic rats. Topical application of WKYMVm onto cutaneous wounds stimulated formation of von Willebrand factor‐positive capillary and α‐smooth muscle actin‐positive arteriole with a maximal stimulation on day 6, suggesting WKYMVm‐stimulated angiogenesis. Infiltration of immune cells could be detected on early phase during wound healing and WKYMVm treatment acutely augmented infiltration of CD68‐positive macrophages. In addition, reepithelialization and granulation tissue formation were accelerated by treatment with WKYMVm. These results suggest that WKYMVm has therapeutic effects on diabetic wounds by stimulating angiogenesis and infiltration of immune cells.
doi_str_mv 10.1111/wrr.12315
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780511960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1709710221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3965-d0ae1b0bf2d7c8d0bbc1f6ae707c3278d1c5d59e91479e9d8733b41f5c25beed3</originalsourceid><addsrcrecordid>eNqNkEtv1TAQRi0EoqVlwR9AXsIirce-tuMlVLQg2lIuj8LKcuxJMc2LONHl_ntM03aHxCxmZnHm0-gQ8gzYAeQ63IzjAXAB8gHZBclXxUrLbw_zzpQuwHC9Q56k9JMxJqUpH5MdLo0WSsIu-fhpiu3cuCn2He1r6ufJddjPiW76uQv0B7omdle02lLX0eOLNS_SgD7W0dMBhykGpO6q72Ka6OX772df233yqHZNwqe3c498OX7z-ehtcfrh5N3Rq9PCC6NkEZhDqFhV86B9GVhVeaiVQ820F1yXAbwM0qCBlc49lFqIagW19FxWiEHskRdL7jD2v2ZMk21j8tg0y_8WdMkkgFHsP1BmNDDOIaMvF9SPfUoj1nYYY-vGrQVm_8q2Wba9kZ3Z57exc9ViuCfv7GbgcAE2scHtv5Ps5Xp9F1ksF9kn_r6_cOO1VVroTJ6fWHWuXhulSivFH8JBl28</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1709710221</pqid></control><display><type>article</type><title>Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Kwon, Yang Woo ; Heo, Soon Chul ; Jang, Il Ho ; Jeong, Geun Ok ; Yoon, Jung Won ; Mun, Je-Ho ; Kim, Jae Ho</creator><creatorcontrib>Kwon, Yang Woo ; Heo, Soon Chul ; Jang, Il Ho ; Jeong, Geun Ok ; Yoon, Jung Won ; Mun, Je-Ho ; Kim, Jae Ho</creatorcontrib><description>ABSTRACT Diabetes is one of the most common human diseases and 15% of the 200 million diabetics worldwide suffer from diabetic wounds. Development of new therapeutic agents is needed for treatment of diabetic wounds. Wound healing is mediated by multiple steps, including inflammation, epithelialization, neoangiogenesis, and granulation. Formyl peptide receptor 2 has been known to stimulate angiogenesis, which is essential for tissue repair and cutaneous wound healing. In this study, we explored the therapeutic effects of WKYMVm (Trp‐Lys‐Tyr‐Met‐Val‐D‐Met‐NH2), a synthetic peptide agonist of formyl peptide receptor 2, on cutaneous wounds in streptozotocin‐induced diabetic rats. Topical application of WKYMVm onto cutaneous wounds stimulated formation of von Willebrand factor‐positive capillary and α‐smooth muscle actin‐positive arteriole with a maximal stimulation on day 6, suggesting WKYMVm‐stimulated angiogenesis. Infiltration of immune cells could be detected on early phase during wound healing and WKYMVm treatment acutely augmented infiltration of CD68‐positive macrophages. In addition, reepithelialization and granulation tissue formation were accelerated by treatment with WKYMVm. These results suggest that WKYMVm has therapeutic effects on diabetic wounds by stimulating angiogenesis and infiltration of immune cells.</description><identifier>ISSN: 1067-1927</identifier><identifier>EISSN: 1524-475X</identifier><identifier>DOI: 10.1111/wrr.12315</identifier><identifier>PMID: 25973651</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Administration, Topical ; Animals ; Chemotactic Factors ; Diabetes Mellitus, Experimental - complications ; Diabetes Mellitus, Experimental - drug therapy ; Diabetes Mellitus, Experimental - metabolism ; Male ; Neovascularization, Physiologic - drug effects ; Oligopeptides - administration &amp; dosage ; Rats ; Rats, Sprague-Dawley ; Receptors, Formyl Peptide - agonists ; Skin - blood supply ; Skin - drug effects ; Skin - pathology ; Skin Ulcer - drug therapy ; Skin Ulcer - etiology ; Skin Ulcer - metabolism ; Treatment Outcome ; Wound Healing - drug effects</subject><ispartof>Wound repair and regeneration, 2015-07, Vol.23 (4), p.575-582</ispartof><rights>2015 by the Wound Healing Society</rights><rights>2015 by the Wound Healing Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3965-d0ae1b0bf2d7c8d0bbc1f6ae707c3278d1c5d59e91479e9d8733b41f5c25beed3</citedby><cites>FETCH-LOGICAL-c3965-d0ae1b0bf2d7c8d0bbc1f6ae707c3278d1c5d59e91479e9d8733b41f5c25beed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fwrr.12315$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fwrr.12315$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25973651$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kwon, Yang Woo</creatorcontrib><creatorcontrib>Heo, Soon Chul</creatorcontrib><creatorcontrib>Jang, Il Ho</creatorcontrib><creatorcontrib>Jeong, Geun Ok</creatorcontrib><creatorcontrib>Yoon, Jung Won</creatorcontrib><creatorcontrib>Mun, Je-Ho</creatorcontrib><creatorcontrib>Kim, Jae Ho</creatorcontrib><title>Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm</title><title>Wound repair and regeneration</title><addtitle>Wound Rep and Reg</addtitle><description>ABSTRACT Diabetes is one of the most common human diseases and 15% of the 200 million diabetics worldwide suffer from diabetic wounds. Development of new therapeutic agents is needed for treatment of diabetic wounds. Wound healing is mediated by multiple steps, including inflammation, epithelialization, neoangiogenesis, and granulation. Formyl peptide receptor 2 has been known to stimulate angiogenesis, which is essential for tissue repair and cutaneous wound healing. In this study, we explored the therapeutic effects of WKYMVm (Trp‐Lys‐Tyr‐Met‐Val‐D‐Met‐NH2), a synthetic peptide agonist of formyl peptide receptor 2, on cutaneous wounds in streptozotocin‐induced diabetic rats. Topical application of WKYMVm onto cutaneous wounds stimulated formation of von Willebrand factor‐positive capillary and α‐smooth muscle actin‐positive arteriole with a maximal stimulation on day 6, suggesting WKYMVm‐stimulated angiogenesis. Infiltration of immune cells could be detected on early phase during wound healing and WKYMVm treatment acutely augmented infiltration of CD68‐positive macrophages. In addition, reepithelialization and granulation tissue formation were accelerated by treatment with WKYMVm. These results suggest that WKYMVm has therapeutic effects on diabetic wounds by stimulating angiogenesis and infiltration of immune cells.</description><subject>Administration, Topical</subject><subject>Animals</subject><subject>Chemotactic Factors</subject><subject>Diabetes Mellitus, Experimental - complications</subject><subject>Diabetes Mellitus, Experimental - drug therapy</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Male</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Oligopeptides - administration &amp; dosage</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Formyl Peptide - agonists</subject><subject>Skin - blood supply</subject><subject>Skin - drug effects</subject><subject>Skin - pathology</subject><subject>Skin Ulcer - drug therapy</subject><subject>Skin Ulcer - etiology</subject><subject>Skin Ulcer - metabolism</subject><subject>Treatment Outcome</subject><subject>Wound Healing - drug effects</subject><issn>1067-1927</issn><issn>1524-475X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtv1TAQRi0EoqVlwR9AXsIirce-tuMlVLQg2lIuj8LKcuxJMc2LONHl_ntM03aHxCxmZnHm0-gQ8gzYAeQ63IzjAXAB8gHZBclXxUrLbw_zzpQuwHC9Q56k9JMxJqUpH5MdLo0WSsIu-fhpiu3cuCn2He1r6ufJddjPiW76uQv0B7omdle02lLX0eOLNS_SgD7W0dMBhykGpO6q72Ka6OX772df233yqHZNwqe3c498OX7z-ehtcfrh5N3Rq9PCC6NkEZhDqFhV86B9GVhVeaiVQ820F1yXAbwM0qCBlc49lFqIagW19FxWiEHskRdL7jD2v2ZMk21j8tg0y_8WdMkkgFHsP1BmNDDOIaMvF9SPfUoj1nYYY-vGrQVm_8q2Wba9kZ3Z57exc9ViuCfv7GbgcAE2scHtv5Ps5Xp9F1ksF9kn_r6_cOO1VVroTJ6fWHWuXhulSivFH8JBl28</recordid><startdate>201507</startdate><enddate>201507</enddate><creator>Kwon, Yang Woo</creator><creator>Heo, Soon Chul</creator><creator>Jang, Il Ho</creator><creator>Jeong, Geun Ok</creator><creator>Yoon, Jung Won</creator><creator>Mun, Je-Ho</creator><creator>Kim, Jae Ho</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201507</creationdate><title>Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm</title><author>Kwon, Yang Woo ; Heo, Soon Chul ; Jang, Il Ho ; Jeong, Geun Ok ; Yoon, Jung Won ; Mun, Je-Ho ; Kim, Jae Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3965-d0ae1b0bf2d7c8d0bbc1f6ae707c3278d1c5d59e91479e9d8733b41f5c25beed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Administration, Topical</topic><topic>Animals</topic><topic>Chemotactic Factors</topic><topic>Diabetes Mellitus, Experimental - complications</topic><topic>Diabetes Mellitus, Experimental - drug therapy</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Male</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Oligopeptides - administration &amp; dosage</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Formyl Peptide - agonists</topic><topic>Skin - blood supply</topic><topic>Skin - drug effects</topic><topic>Skin - pathology</topic><topic>Skin Ulcer - drug therapy</topic><topic>Skin Ulcer - etiology</topic><topic>Skin Ulcer - metabolism</topic><topic>Treatment Outcome</topic><topic>Wound Healing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kwon, Yang Woo</creatorcontrib><creatorcontrib>Heo, Soon Chul</creatorcontrib><creatorcontrib>Jang, Il Ho</creatorcontrib><creatorcontrib>Jeong, Geun Ok</creatorcontrib><creatorcontrib>Yoon, Jung Won</creatorcontrib><creatorcontrib>Mun, Je-Ho</creatorcontrib><creatorcontrib>Kim, Jae Ho</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Wound repair and regeneration</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kwon, Yang Woo</au><au>Heo, Soon Chul</au><au>Jang, Il Ho</au><au>Jeong, Geun Ok</au><au>Yoon, Jung Won</au><au>Mun, Je-Ho</au><au>Kim, Jae Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm</atitle><jtitle>Wound repair and regeneration</jtitle><addtitle>Wound Rep and Reg</addtitle><date>2015-07</date><risdate>2015</risdate><volume>23</volume><issue>4</issue><spage>575</spage><epage>582</epage><pages>575-582</pages><issn>1067-1927</issn><eissn>1524-475X</eissn><abstract>ABSTRACT Diabetes is one of the most common human diseases and 15% of the 200 million diabetics worldwide suffer from diabetic wounds. Development of new therapeutic agents is needed for treatment of diabetic wounds. Wound healing is mediated by multiple steps, including inflammation, epithelialization, neoangiogenesis, and granulation. Formyl peptide receptor 2 has been known to stimulate angiogenesis, which is essential for tissue repair and cutaneous wound healing. In this study, we explored the therapeutic effects of WKYMVm (Trp‐Lys‐Tyr‐Met‐Val‐D‐Met‐NH2), a synthetic peptide agonist of formyl peptide receptor 2, on cutaneous wounds in streptozotocin‐induced diabetic rats. Topical application of WKYMVm onto cutaneous wounds stimulated formation of von Willebrand factor‐positive capillary and α‐smooth muscle actin‐positive arteriole with a maximal stimulation on day 6, suggesting WKYMVm‐stimulated angiogenesis. Infiltration of immune cells could be detected on early phase during wound healing and WKYMVm treatment acutely augmented infiltration of CD68‐positive macrophages. In addition, reepithelialization and granulation tissue formation were accelerated by treatment with WKYMVm. These results suggest that WKYMVm has therapeutic effects on diabetic wounds by stimulating angiogenesis and infiltration of immune cells.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25973651</pmid><doi>10.1111/wrr.12315</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1067-1927
ispartof Wound repair and regeneration, 2015-07, Vol.23 (4), p.575-582
issn 1067-1927
1524-475X
language eng
recordid cdi_proquest_miscellaneous_1780511960
source MEDLINE; Wiley Online Library
subjects Administration, Topical
Animals
Chemotactic Factors
Diabetes Mellitus, Experimental - complications
Diabetes Mellitus, Experimental - drug therapy
Diabetes Mellitus, Experimental - metabolism
Male
Neovascularization, Physiologic - drug effects
Oligopeptides - administration & dosage
Rats
Rats, Sprague-Dawley
Receptors, Formyl Peptide - agonists
Skin - blood supply
Skin - drug effects
Skin - pathology
Skin Ulcer - drug therapy
Skin Ulcer - etiology
Skin Ulcer - metabolism
Treatment Outcome
Wound Healing - drug effects
title Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A48%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stimulation%20of%20cutaneous%20wound%20healing%20by%20an%20FPR2-specific%20peptide%20agonist%20WKYMVm&rft.jtitle=Wound%20repair%20and%20regeneration&rft.au=Kwon,%20Yang%20Woo&rft.date=2015-07&rft.volume=23&rft.issue=4&rft.spage=575&rft.epage=582&rft.pages=575-582&rft.issn=1067-1927&rft.eissn=1524-475X&rft_id=info:doi/10.1111/wrr.12315&rft_dat=%3Cproquest_cross%3E1709710221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1709710221&rft_id=info:pmid/25973651&rfr_iscdi=true